OTC Watch

All stocks / BTCY

BIOTRICITY INC. BTCY

Biotricity (BTCY): a late 10-Q notice in August 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated floatLate filing OTCQBCalifornia, USA
Live quote on OTC Markets

Market listing

Full name
BIOTRICITY INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 16
Website
biotricity.com
Source: Stockwatch, 2026-11-17

News headlines

Biotricity, Inc to Present at the LD Micro Invitational XVI
2026-05-12 08:16 · News Release
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
2026-02-11 16:00 · News Release
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th
2026-02-05 16:15 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2026-03-31
The report says
Revenue
$15,998,239
Net loss
($2,404,139)
What it means

It spends more than it earns

Under strain

Customers paid it $16 million in the year. It lost $2.4 million. For every $1 that came in, about $1.15 went out.

The report says
Cash and cash equivalents
$149,789
Net cash used in operating activities
($718,955)
What it means

The cash could run out soon

Under strain

It had $149,789 in the bank and used about $59,913 a month. At that pace the money lasts about 3 months unless it borrows or sells more shares.

The report says
Total assets
$6,446,488
Total liabilities
$39,408,954
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $6.4 million. Its debts and unpaid bills add up to $39.4 million. That is about $6.11 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-11-16

Estimated float about 21,631,493 shares as of 2026-11-16: 21,631,493 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-08-17

Filed NT 10-Q on 2026-08-17: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-06-29

Filed NT 10-K on 2026-06-29: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-12-31
27.8M
2026-02-11
28.4M
2026-03-31
28.6M
2026-06-30
20.1M
2026-07-14
20.1M
2026-08-19
19.9M
2026-09-30
21.6M
2026-11-16
21.6M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 10-Q10-Q
2026-11-12 SCHEDULE 13G/A
2026-10-07 RWRW
2026-09-28 8-K8-K
2026-08-19 10-Q10-Q
2026-08-17 NT 10-QNT 10-Q
2026-08-14 SCHEDULE 13G/A
2026-07-14 10-K10-K
2026-06-29 NT 10-KNT 10-K
2026-06-16 DEF 14CDEF 14C
2026-05-29 PRE 14CPRE 14C
2026-05-12 SCHEDULE 13G/A

Common questions about BTCY

Does BTCY file reports with the SEC?

Yes. Biotricity files with the SEC under company number 0001630113. The most recent filing we hold is a 10-Q dated 2026-11-16.

Source record

How many BTCY shares are outstanding?

21,631,493 shares as of 2026-11-16, as reported to the SEC.

Source record

Has BTCY filed reports late?

Yes. In the last 12 months it filed 2 late-filing notices, most recently a NT 10-Q on 2026-08-17. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Biotricity making money?

Customers paid it $16 million in the year. It lost $2.4 million. For every $1 that came in, about $1.15 went out. (Annual figures to 2026-03-31. Facts from the company's own report, not a recommendation.)

Source record